IRF2BPL as a novel causative gene for progressive myoclonus epilepsy
- PMID: 37114479
- DOI: 10.1111/epi.17634
IRF2BPL as a novel causative gene for progressive myoclonus epilepsy
Abstract
IRF2BPL has recently been described as a novel cause of neurodevelopmental disorders with multisystemic regression, epilepsy, cerebellar symptoms, dysphagia, dystonia, and pyramidal signs. We describe a novel IRF2BPL phenotype consistent with progressive myoclonus epilepsy (PME) in three novel subjects and review the features of the 31 subjects with IRF2BPL-related disorders previously reported. Our three probands, aged 28-40 years, harbored de novo nonsense variants in IRF2BPL (c.370C > T, p.[Gln124*] and c.364C > T; p.[Gln122*], respectively). From late childhood/adolescence, they presented with severe myoclonus epilepsy, stimulus-sensitive myoclonus, and progressive cognitive, speech, and cerebellar impairment, consistent with a typical PME syndrome. The skin biopsy revealed massive intracellular glycogen inclusions in one proband, suggesting a similar pathogenic pathway to other storage disorders. Whereas the two older probands were severely affected, the younger proband had a milder PME phenotype, partially overlapping with some of the previously reported IRF2BPL cases, suggesting that some of them might be unrecognized PME. Interestingly, all three patients harbored protein-truncating variants clustered in a proximal, highly conserved gene region around the "coiled-coil" domain. Our data show that PME can be an additional phenotype within the spectrum of IRF2BPL-related disorders and suggest IRF2BPL as a novel causative gene for PME.
Keywords: IRF2BPL; ataxia; cerebellar signs; neurodevelopmental disorder; progressive myoclonus epilepsy.
© 2023 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.
References
REFERENCES
-
- Michelucci R, Serratosa JM, Delgado-Escueta AV, Genton P, Riguzzi P, Tassinari CA. Progressive myoclonic epilepsies. In: Bureau M, Genton P, Dravet C, Delgado-Escueta AV, Guerrini R, Tassinari CA, et al., editors. Epileptic syndromes in infancy, childhood and adolescence. 6th ed. Montrouge, Ile-de-France: John Libbey Eurotext; 2019. p. 571-610.
-
- Canafoglia L, Franceschetti S, Gambardella A, Striano P, Giallonardo AT, Tinuper P, et al. Progressive myoclonus epilepsies. Diagnostic yield with next-generation sequencing in previously unsolved cases. Neurol Genet. 2021;7:e641.
-
- Marcogliese PC, Shashi V, Spillmann RC, Stong N, Rosenfeld JA, Koenig MK, et al. IRF2BPL is associated with neurological phenotypes. Am J Hum Genet. 2018;103:245-60.
-
- Tran Mau-Them F, Guibaud L, Duplomb L, Keren B, Lindstrom K, Marey I, et al. De novo truncating variants in the intronless IRF2BPL are responsible for developmental epileptic encephalopathy. Genet Med. 2019;21:1008-14.
-
- Ganos C, Biskup S, Krüger S, Meyer-Osores A, Hodecker S, Hagel C, et al. Dystonia with aphonia, slow horizontal saccades, epilepsy and photic myoclonus: a novel syndrome? Parkinsonism Relat Disord. 2014;20:328-31.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
